Nir Eyal
#98,936
Most Influential Person Now
Bioethicist
Nir Eyal 's AcademicInfluence.com Rankings
Nir Eyal philosophy Degrees
Philosophy
#6686
World Rank
#9767
Historical Rank
Bioethics
#73
World Rank
#73
Historical Rank
Download Badge
Philosophy
Why Is Nir Eyal Influential?
(Suggest an Edit or Addition)According to Wikipedia, Nir Eyal is a bioethicist and Henry Rutgers Professor of Bioethics and Director of the Center for Population–Level Bioethics at Rutgers University in New Jersey. He was formerly a bioethicist in the Department of Global Health and Population of the Harvard T.H. Chan School of Public Health and the Department of Global Health and Social Medicine of the Harvard Medical School. He has long worked closely with Harvard bioethicist Daniel Wikler. Eyal's current visibility concerns his role in studying the ethics of human challenge trials in HIV, malaria, and coronavirus vaccine development. He has also written on 'bystander risks' during pandemics and infectious diseases and contract tracing during ebola.
Nir Eyal 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International AIDS Society global scientific strategy: towards an HIV cure 2016 (2016) (372)
- Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure (2020) (193)
- Reframing Consent for Clinical Research: A Function-Based Approach (2017) (89)
- Contact tracing performance during the Ebola epidemic in Liberia, 2014-2015 (2018) (89)
- Inequalities in health : concepts, measures, and ethics (2013) (86)
- Non-Physician Clinicians in Sub-Saharan Africa and the Evolving Role of Physicians (2015) (57)
- Using informed consent to save trust (2012) (53)
- Physician brain drain : can nothing be done? (2008) (51)
- Ethical Questions in Medical Electronic Adherence Monitoring (2016) (43)
- The Diverse Ethics of Translational Research (2010) (37)
- Medical students’ characteristics as predictors of career practice location: retrospective cohort study tracking graduates of Nepal’s first medical college (2012) (37)
- ‘Perhaps the most important primary good’: self-respect and Rawls’s principles of justice (2005) (35)
- Challenges in clinical trial design for HIV-1 cure research (2013) (35)
- Nudging by Shaming, Shaming by Nudging (2014) (34)
- From Doxastic to Epistemic: A Typology and Critique of Qualitative Interview Styles (2018) (31)
- Choices in vaccine trial design in epidemics of emerging infections (2018) (31)
- Identified versus statistical lives : an interdisciplinary perspective (2015) (29)
- The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction (2016) (25)
- Egalitarian Justice and Innocent Choice (2017) (24)
- Opinion: Risk to study nonparticipants: A procedural approach (2018) (23)
- Scaling up changes in doctors' education for rural retention: a comment on World Health Organization recommendations. (2011) (22)
- Improving vaccine trials in infectious disease emergencies (2017) (22)
- Why Challenge Trials of SARS‐CoV‐2 Vaccines Could Be Ethical Despite Risk of Severe Adverse Events (2020) (21)
- Denial of Treatment to Obese Patients-the Wrong Policy on Personal Responsibility for Health. (2013) (21)
- Ethical issues in HIV remission trials (2018) (20)
- HIV Treatment-as-Prevention Research at a Crossroads (2014) (20)
- Overcoming HIV Stigma? A Qualitative Analysis of HIV Cure Research and Stigma Among Men Who Have Sex with Men Living with HIV (2018) (18)
- Allocating Medical Resources in the Time of Covid-19. (2020) (17)
- REPEAT TRIAGE IN DISASTER RELIEF: QUESTIONS FROM HAITI (2012) (17)
- Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium (2019) (17)
- Precommitting to Serve the Underserved (2012) (16)
- Intralesional cryosurgery for the treatment of basal cell carcinoma of the lower extremities in elderly subjects: a feasibility study (2016) (16)
- Ebola and beyond (2015) (15)
- How to keep high-risk studies ethical: classifying candidate solutions (2016) (15)
- Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines (2020) (14)
- Is the Body Special? Review of Cécile Fabre, Whose Body is it Anyway? Justice and the Integrity of the Person (2009) (13)
- Vaccine testing for emerging infections: the case for individual randomisation (2017) (13)
- Adding Lithium to Drinking Water for Suicide Prevention—The Ethics (2019) (12)
- Three Case Studies in Making Fair Choices on the Path to Universal Health Coverage (2016) (12)
- A staff support programme for rural hospitals in Nepal (2015) (11)
- Can Rationing Through Inconvenience Be Ethical? (2018) (11)
- Making Fair Choices on the Path to Universal Health Coverage: Applying Principles to Difficult Cases (2017) (10)
- The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda (2018) (10)
- Broad cross-national public support for accelerated COVID-19 vaccine trial designs (2020) (9)
- Too Poor To Treat? The Complex Ethics of Cost-Effective Tobacco Policy in the Developing World (2011) (9)
- HIV Cure Research: Risks Patients Expressed Willingness to Accept. (2019) (9)
- Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere (2018) (9)
- Is There a Moral Right to Nonmedical Vaccine Exemption? (2016) (9)
- Paying for antiretroviral adherence: is it unethical when the patient is an adolescent? (2016) (9)
- AIDS Activism and Coronavirus Vaccine Challenge Trials (2020) (8)
- What can the lived experience of participating in risky HIV cure-related studies establish? (2018) (8)
- Response to Cioffi. (2020) (8)
- When Ancillary Care Clashes with Study Aims. (2017) (8)
- How to Address the Risk of HIV Transmission in Remission Studies With Treatment Interruption: The Low-Hanging Fruit Approach (2019) (8)
- What risk of death would people take to be cured of HIV and why? A survey of people living with HIV (2019) (8)
- How to Test Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines Ethically Even After One Is Available (2021) (7)
- Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies (2021) (7)
- Regulating impact on bystanders in clinical trials: An unsettled frontier (2019) (6)
- Near-Universal Basic Income (2010) (6)
- When Global ART Budgets Cannot Cover All Patients, Who Should Be Eligible? (2019) (6)
- Testing SARS-CoV-2 vaccine efficacy through deliberate natural viral exposure (2021) (5)
- Luck Egalitarianism, Harshness, and the Rule of Rescue (2016) (5)
- Pediatric Heart Surgery in Ghana: Three Ethical Questions (2014) (5)
- Is it ethical to isolate study participants to prevent HIV transmission during trials with an analytical treatment interruption? (2019) (5)
- Equality and Egalitarianism (2012) (5)
- “Cure” Versus “Clinical Remission”: The Impact of a Medication Description on the Willingness of People Living with HIV to Take a Medication (2020) (5)
- Reconciling informed consent with prescription drug requirements (2012) (5)
- Introduction : what’s wrong with health inequalities? (2013) (4)
- Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge (2017) (4)
- Removing One Barrier to Protecting Sex Partners in HIV Remission Studies With a Treatment Interruption (2019) (4)
- Rescuing vapers vs. rescuing smokers: the ethics. (2020) (4)
- Characterizing altruistic motivation in potential volunteers for SARS-CoV-2 challenge trials (2021) (4)
- COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies (2021) (4)
- Motivating prevention: from carrots and sticks to "carrots" and "sticks". (2008) (4)
- Informed consent, the value of trust, and hedons (2013) (4)
- Concentrated Risk, the Coventry Blitz, Chamberlain’s Cancer (2015) (4)
- Leveling Down Health (2013) (4)
- On Knowingly Setting Unrealistic Goals in Public Health. (2020) (4)
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem? (2021) (3)
- Unnecessary hesitancy on human vaccine tests (2020) (3)
- “Thought provoking”, “interactive”, and “more like a peer talk”: Testing the deliberative interview style in Germany (2021) (3)
- Inequalities in HIV Care: Chances Versus Outcomes (2011) (3)
- Electronic Adherence Monitoring May Facilitate Intentional HIV Status Disclosure Among People Living with HIV in Rural Southwestern Uganda (2021) (3)
- Why treat noncompliant patients? Beyond the decent minimum account. (2011) (3)
- Nudges and Noodges: The Ethics of Health Promotion—New York Style (2013) (3)
- Maximising the global health impact of future HIV cure-related interventions through advance planning (2018) (3)
- Chapter 11 – Ethical Issues in Disaster Medicine (2016) (3)
- Risk to bystanders in clinical trials: A symposium (2019) (3)
- Conditioning Medical Scholarships on Long, Future Service (2013) (3)
- Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests (2021) (3)
- Coercion in the Fight Against Medical Brain Drain (2010) (3)
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement (2021) (2)
- Input and output in distributive theory (2021) (2)
- Inequality in Political Philosophy and in Epidemiology: A Remarriage (2015) (2)
- Ethical complexities of responding to bystander risk in HIV prevention trials (2019) (2)
- Informed consent to participation in interventional studies: second-order in a different sense (2015) (2)
- Measuring Health-State Utility via Cured Patients (2020) (2)
- Response to Dawson et al. (2020) (2)
- Standard of care versus second-best: Ethical dilemmas in surgery for high risk papillary thyroid cancer in low and middle-income countries (2015) (2)
- HIV Treatment-As-Prevention Research: Authors’ Reply (2015) (2)
- Informed consent (2018) (2)
- Incommensurability and Trade (2016) (2)
- Symposium on risks to bystanders in clinical research: An introduction. (2020) (2)
- Dependence on Digital Medicine in Resource-Limited Settings (2018) (2)
- Global-Health Impact Labels (2015) (2)
- A Meta-Analysis of the Effectiveness of the “But You Are Free” Compliance-Gaining Technique (2013) (2)
- [Takotsubo cardiomyopathy following surgical intervention for treatment of bowel obstruction]. (2014) (1)
- SARS-CoV-2 Human Challenge Studies. (2021) (1)
- Paternalism, French fries and the weak-willed Witness (2013) (1)
- Symposium: ethics of economic ordeals (2020) (1)
- Consent Requirements for Testing Health Policies: An Intercontinental Comparison of Expert Opinions (2022) (1)
- The Ethics of Human Challenge Trials Using Emerging SARS-CoV-2 Virus Variants. (2021) (1)
- Identified Versus Statistical Lives: An Interdisciplinary Perspective (Front Matter and Introduction) (2015) (1)
- Cruel and Unusual Care and Punishment: Epistemic Injustices in Correctional Health Care (2014) (1)
- Invited Commentary on Dubé et al. (Perceptions of Equipoise, Risk/Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States—A Qualitative Inquiry): Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Heal (2018) (1)
- Obamacare and Conscientious Objection. Some Introductory Thoughts (2013) (1)
- Translational Research Beyond Approval: A Two-Stage Ethics Review (2010) (1)
- Nudge, embarrassment, and restriction-replies to Voigt, Tieffenbach, and Saghai. (2014) (1)
- One lesson of COVID-19: Conduct more health policy trials (2022) (1)
- Introduction: Philosophy and the Global Burden of Disease Study (2020) (1)
- Pneumomediastinum, pneumothorax and subcutaneous emphysema following cryoinsufflation for the treatment of hidradenitis suppurativa (2017) (1)
- Correction to: Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere (2018) (1)
- Ethical Comparators in Coronavirus Vaccine Trials (2020) (1)
- Paired Publication: A Way to Lower One Barrier between Philosophical Insight and Bioethics (2022) (1)
- [TURNOVER CAPSULAR FLAPS FOR THE TREATMENT OF IMPENDING EXTRUSION OF SILICONE PROSTHESIS IN RECONSTRUCTED BREASTS]. (2015) (0)
- Reply (2019) (0)
- Study bystanders and ethical treatment of study participants-A proof of concept. (2020) (0)
- The influence of preoperative overnight fasting under insulin resistance in patients to undergo a videolaparoscopic cholecystectomy (2012) (0)
- 52 How to keep high-risk early-phase HIV cure and long-term remission studies ethical: classifying candidate solutions (2016) (0)
- A new day for human challenge trials? (2022) (0)
- Sticking with Carrots and Sticks (Sticking Points Aside): A Response to Ventakapuram, Goldberg, and Forrow (2013) (0)
- Overcoming HIV Stigma? A Qualitative Analysis of HIV Cure Research and Stigma Among Men Who Have Sex with Men Living with HIV (2017) (0)
- Pandemic vaccine testing: Combining conventional and challenge studies (2022) (0)
- Rescuing Vapers Versus Rescuing Smokers: The Ethics (2021) (0)
- Afterword: returning to philosophical foundations in research ethics (2016) (0)
- COP27: The Prospects and Challenges for the Middle East and North Africa (MENA) (2022) (0)
- The establishment of a microvascular free flap service in a medium-sized hospital (500 beds)—an eight-year experience (2019) (0)
- Appropriate Health Resource Rationing in a Non-Ideal World. (2019) (0)
- Global Health and the Changing Contours of Human Life (2018) (0)
- Coordinating Between Medical Professions’ Tasks to Optimize Sub-Saharan Health Systems: A Response to Recent Commentaries (2016) (0)
- Coronavirus Disease 2019 (COVID-19) Vaccine Prioritization in Low- and Middle-Income Countries May Justifiably Depart From High-Income Countries’ Age Priorities (2022) (0)
- “The research assistants kept coming to follow me up; I counted myself as a lucky person”: Social support arising from a longitudinal HIV cohort study in Uganda (2022) (0)
- Reply to Hasford and to Spinola et al. (2020) (0)
- All research that might result in a pandemic must undergo external review. (2023) (0)
- Do Health Workers have A Duty to Work in Underserved Areas (2014) (0)
- Mass drug administration of azithromycin: an analysis. (2022) (0)
- Justice, Luck, and Knowledge, by Susan L. Hurley. Harvard University Press, 2003. viii + 341 pages (2005) (0)
- Two Kinds of To-Kind Benefits and Other Reasons Why Shared Vulnerability Can Keep Clinical Studies Ethical (2014) (0)
- Introduction to Part I—Regulation of Risk (2014) (0)
- A fallacious argument (2018) (0)
- Non-Consequentialist Utilitarianism (2014) (0)
- Mary Rorty and Mark Sheldon ARTICLES John Kleinig Correctional Health Care : Further Reflections Nada (2014) (0)
- Obamacare and Conscientious Objection (2013) (0)
- Support for UNRWA's survival (2018) (0)
- The ethical case for placebo control in HIV-cure-related studies with ART interruption (2022) (0)
- Opinion: It’s ethical to test promising coronavirus vaccines against less-promising ones (2020) (0)
- Medical Tourism in South Asia: Moving From Brain Drain to Brain Gain (2012) (0)
- A method for maintaining the earring tract during the replacement of a temporary earring to a permanent one following repair of a cleft earlobe (2014) (0)
- Symposium on the ethics of economic ordeals: Introduction (2020) (0)
- Statistical versus Identified Persons (2015) (0)
- Research ethics and public trust in vaccines: the case of COVID-19 challenge trials (2022) (0)
- The phantasm of zero suicide. (2023) (0)
- A Misleading Cite (2017) (0)
- Is There an Ethical Upper Limit on Risks to Study Participants? (2020) (0)
This paper list is powered by the following services:
Other Resources About Nir Eyal
What Schools Are Affiliated With Nir Eyal ?
Nir Eyal is affiliated with the following schools:
